Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.
…
continue reading
Content provided by Oncology Data Advisor® and I3 Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Oncology Data Advisor® and I3 Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Caring for Patients Receiving CAR T-Cell Therapy
MP3•Episode home
Manage episode 342607644 series 1163940
Content provided by Oncology Data Advisor® and I3 Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Oncology Data Advisor® and I3 Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this interview with Oncology Data Advisor, Dr. Joshua Sasine, Hematologist-Oncologist at Cedars-Sinai Medical Center, discusses the factors that make patients suitable candidates for chimeric antigen receptor (CAR) T-cell therapy, strategies to minimize the unique toxicities associated with these treatments, and the future of the use of CAR T-cell therapy in the outpatient setting.
…
continue reading
397 episodes
MP3•Episode home
Manage episode 342607644 series 1163940
Content provided by Oncology Data Advisor® and I3 Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Oncology Data Advisor® and I3 Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this interview with Oncology Data Advisor, Dr. Joshua Sasine, Hematologist-Oncologist at Cedars-Sinai Medical Center, discusses the factors that make patients suitable candidates for chimeric antigen receptor (CAR) T-cell therapy, strategies to minimize the unique toxicities associated with these treatments, and the future of the use of CAR T-cell therapy in the outpatient setting.
…
continue reading
397 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.